Stock Fundamentals

Company Information

Company Name
Beyond Air Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US08862L1035
CIK: 0001641631
CUSIP: 08862L103
Currency: USD
Full Time Employees: 54
Phone: 516 665 8200
Fiscal Year End: March
IPO Date: Sep 22, 2017
Description:

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.

Address:

900 Stewart Avenue, Garden City, NY, United States, 11530

Directors & Officers

Name Title Year Born
Mr. Robert Scott Goodman CEO & Director 1965
Mr. Daniel J. Moorhead CPA Chief Financial Officer 1972
Mr. Michael A. Gaul Chief Operating Officer 1955
Mr. Denton Drewell Principal Accounting Officer & Controller 1987
Dr. Andrew R. Colin M.D. Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board NA
Dr. John Jett Ph.D. Head of Research & Clinical Development NA
Mr. Amir Avniel Chief Executive Officer of NeuroNOS 1974
Mr. Adam T. Newman Corporate Secretary NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 14, 2025 Robert Carey N/A Purchase 50.00K $5.00 $250.00K
Feb 19, 2025 Michael A Gaul N/A Purchase 300.00 $7.60 $2.28K
Sep 26, 2024 Steven A Lisi N/A Purchase 73.83K $10.00 $738.31K
Aug 14, 2024 Erick Lucera N/A Purchase 1.96K $8.00 $15.70K
Aug 14, 2024 Steven A Lisi N/A Purchase 5.00K $7.80 $39.00K
Dec 28, 2023 Amir Avniel N/A Sale 563.00 $41.20 $23.20K
Dec 18, 2023 Robert Carey N/A Purchase 60.00K $32.80 $1.97M
Dec 18, 2023 Steven A Lisi N/A Purchase 3.89K $32.60 $126.75K
Aug 28, 2023 Robert Carey N/A Purchase 12.50K $53.80 $672.50K
Aug 21, 2023 Robert Carey N/A Purchase 3.75K $55.20 $207.11K
Aug 18, 2023 Robert Carey N/A Purchase 680.00 $52.80 $35.90K
Jun 30, 2023 Michael A Gaul N/A Purchase 250.00 $90.20 $22.55K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Balyasny Asset Management LLC 464.16K Mar 31, 2026 3.66% $0.00 0.00%
Murchinson Ltd. 329.99K Mar 31, 2026 2.60% $0.03 0.00%
Geode Capital Management, LLC 159.44K Mar 31, 2026 1.26% $0.00 135.59%
Daytona Street Capital LLC 156.85K Mar 31, 2026 1.24% $0.09 0.00%
Bleichroeder LP 86.49K Mar 31, 2026 0.68% $0.01 0.00%
Vanguard Group Inc 60.44K Dec 31, 2025 0.48% $0.00 -42.12%
Vanguard Capital Management, LLC 31.94K Mar 31, 2026 0.25% $0.00 0.00%
Vanguard Fiduciary Trust Co 29.37K Mar 31, 2026 0.23% $0.00 0.00%
WEALTH EFFECTS LLC 28.36K Mar 31, 2026 0.22% $0.01 -10.50%
Jane Street Group LLC 27.52K Mar 31, 2026 0.22% $0.00 -17.42%
BlackRock Inc 22.03K Mar 31, 2026 0.17% $0.00 0.00%
Baldwin Brothers Inc 14.80K Mar 31, 2026 0.12% $0.00 0.00%
XTX Topco Ltd 12.07K Mar 31, 2026 0.10% $0.00 -33.76%
Virtu Financial LLC 10.80K Mar 31, 2026 0.09% $0.00 -11.23%
Advisor Group Holdings, Inc. 8.12K Mar 31, 2026 0.06% $0.00 0.00%
Tower Research Capital LLC 4.58K Mar 31, 2026 0.04% $0.00 -38.15%
PFS Partners, LLC 2.00K Mar 31, 2026 0.02% $0.00 0.00%
IFP Advisors, LLC 1.14K Mar 31, 2026 0.01% $0.00 0.00%
Group One Trading, LP 615.00 Dec 31, 2025 0.00% $0.00 -6.25%
Vanguard Global Advisers, LLC 539.00 Mar 31, 2026 0.00% $0.00 0.00%

Shares Statistics

Shares Outstanding: 720.53K
Shares Float: 14.12M
% Insiders: 214.10%
% Institutions: 966.50%
Short % Float: 2.35%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 121.36K 0.96% ▼ 0.36% Apr 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 31.94K 0.25% ▲ 0.00% Apr 30, 2026
3 Spartan Extended Market Index Pool F 18.51K 0.15% ▲ 2.45% Apr 30, 2026
4 Fidelity Total Market Index 8.13K 0.06% ▲ 0.00% Apr 30, 2026
5 Fidelity Series Total Market Index 6.36K 0.05% ▲ 0.00% Apr 30, 2026
6 Spartan Total Market Index Pool G 3.37K 0.03% ▲ 0.00% Apr 30, 2026
7 Extended Equity Market Fund E 3.25K 0.03% ▲ 0.00% Dec 31, 2025
8 Blackrock Extended Mkt Fund CF 3.25K 0.03% ▲ 0.00% Apr 30, 2026
9 Extended Equity Market Fund B 3.25K 0.03% ▲ 0.00% Dec 31, 2025
10 BlackRock Extended Equity Market Fund K 2.77K 0.02% ▼ 0.72% Mar 31, 2026

Valuation Metrics

Enterprise Value: $17.68M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $300.46K
EBITDA: $-25.79M
Book Value: $0.97
Earnings/Share: $-80.20
Profit Margin: 0.00%
Operating Margin: -375.98%
ROA (TTM): -55.47%
ROE (TTM): -334.14%
Revenue (TTM): $7.68M
Revenue/Share (TTM): $0.93
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 65.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2026-03-31 3.80x 3.65x 0.82x -8.26x -0.82x
2025-03-31 3.20x 0.75x 0.52x -14.75x -0.24x
2024-03-31 3.80x 0.64x 0.52x -21.64x -0.27x
2023-03-31 3.00x 0.14x 0.39x -1,735.30x -0.10x
2022-03-31 8.68x 0.12x 0.21x -52.53x -0.22x
2021-03-31 9.80x 0.17x 0.25x -34.60x -0.23x
2020-03-31 5.46x 0.26x 0.34x -593.98x -0.24x
2019-03-31 1.61x 0.07x 0.57x -2,030.91x -0.04x
2018-03-31 4.27x 0.02x 0.83x -10.44x 0.00x
2017-03-31 0.19x -116.26x 5.23x -63.39x -682.45x
2016-03-31 0.19x -1.19x 5.23x N/A -0.01x
2015-03-31 0.64x -0.03x 3.17x N/A -0.01x
2014-03-31 0.18x -0.04x 2.20x N/A -0.01x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about XAIR.US!